Article Text
PDFEducation
What do we mean by the term “inflammation”? A contemporary basic science update for sports medicine
Abstract
Most practicing sports medicine clinicians refer to the concept of “inflammation” many times a day when diagnosing and treating acute and overuse injuries. What is meant by this term? Is it a “good” or a “bad” process? The major advances in the understanding of inflammation in recent years are summarised, and some clinical implications of the contemporary model of inflammation are highlighted.
- inflammation
- injury
- pathophysiology
- anti-inflammatory drugs
- bFGF, basic fibroblast growth factor
- CGRP, calcitonin gene related peptide
- COX, cyclooxygenase
- EGF, endothelial growth factor
- IL, interleukin
- MCP, monocyte chemoattractant protein
- MMP, matrix metalloproteinase
- NGF, nerve growth factor
- NSAID, non-steroidal anti-inflammatory drug
- PDGF, platelet derived growth factor
- PG, prostaglandin
- SP, substance P
- TGF, transforming growth factor
- TNF, tumour necrosis factor
- VEGF, vascular endothelial growth factor
Statistics from Altmetric.com
- bFGF, basic fibroblast growth factor
- CGRP, calcitonin gene related peptide
- COX, cyclooxygenase
- EGF, endothelial growth factor
- IL, interleukin
- MCP, monocyte chemoattractant protein
- MMP, matrix metalloproteinase
- NGF, nerve growth factor
- NSAID, non-steroidal anti-inflammatory drug
- PDGF, platelet derived growth factor
- PG, prostaglandin
- SP, substance P
- TGF, transforming growth factor
- TNF, tumour necrosis factor
- VEGF, vascular endothelial growth factor